title: Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.
authors.affiliation: Lung Cancer Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy Biopolymers and Proteomics Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy Lung Cancer Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy Molecular Oncology and Angiogenesis Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy Lung Cancer Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy Dipartimento di Medicina Interna e Specialità Mediche (DIMI), IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy, UOC Clinica di Oncologia Medica, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro Genova, Italy Lung Cancer Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Coco
authors.forename: Anna
authors.initials: A
authors.lastname: Truini
authors.forename: Irene
authors.initials: I
authors.lastname: Vanni
authors.forename: Carlo
authors.initials: C
authors.lastname: Genova
authors.forename: Camillo
authors.initials: C
authors.lastname: Rosano
authors.forename: Maria Giovanna
authors.initials: MG
authors.lastname: Dal Bello
authors.forename: Angela
authors.initials: A
authors.lastname: Alama
authors.forename: Roberta
authors.initials: R
authors.lastname: Venè
authors.forename: Erika
authors.initials: E
authors.lastname: Rijavec
authors.forename: Giulia
authors.initials: G
authors.lastname: Barletta
authors.forename: Federica
authors.initials: F
authors.lastname: Biello
authors.forename: Francesco
authors.initials: F
authors.lastname: Boccardo
authors.forename: Francesco
authors.initials: F
authors.lastname: Grossi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D020125:Mutation, Missense / Q000235:genetics*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors